Although Exact Sciences’ Cologuard completed its 2 millionth test, the multitarget stool DNA test remains a topic of contention in the gastroenterology space. Touting 92 percent sensitivity and 87 ...
Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People
MADISON, Wis., April 28, 2021 /PRNewswire/ -- Exact Sciences (NASDAQ: EXAS) today announces study results published in Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback